Assessment of Physical Performance With A Supplementation Containing HMB in a Sample of Old Women in Good Health

Age Related Muscle Loss Clinical Trial

— HMB  

Official title:

Role of Oral Supplementation of Proteins and β-hydroxy-β-methyl Butyrate (HMB) in a Sample of Older Women in Good Health

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02118181
• Other study ID #: Not Avalaible
• Status: Completed
• Phase: N/A
• First received: April 16, 2014
• Last updated: December 2, 2014
• Start date: February 2014
• Est. completion date: June 2014

Study information

• Verified date: April 2014
• Source: University of Padova
• Contact: n/a
• Is FDA regulated: No
• Health authority: Italy: Ethics Committee
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether a supplementation containing β-Hydroxy-β-methylbutyrate is effective in the treatment of age-related muscle loss in a group of older women compared to a non interventional group

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: June 2014
• Est. primary completion date: June 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• People over 65 years, not residents in nursing home, in good health

• Mini Mental State Examination (corrected for scholarity) more than 23

Exclusion Criteria:

• Previous oral supplementation with proteins or minerals

• important co-mordidities, such renal or hepatic failure

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Age Related Muscle Loss

Intervention

Dietary Supplement:
• HMB

Locations

Country	Name	City	State
Italy	University of Padova	Padua

Sponsors (1)

Lead Sponsor	Collaborator
University of Padova

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Short Physical Performance Battery		Baseline and after 2 months	No